Home › Pharmaceuticals
Pharmaceuticals Market Research Report
The global pharmaceuticals market is experiencing constant growth due to the worldwide increase in life expectancy, as well as the increasing incidence of chronic and infectious diseases. The steadily increasing demand for innovative drugs has thus triggered a significant rise in R&D investments in the pharmaceuticals industry. Leading industry players allocate around 20% of their turnover to R&D to maintain a competitive edge. The emergence of biopharmaceuticals has opened a new arena for drug discovery; and breakthroughs in the fields of proteomics and genomics have also enabled drug manufacturers to develop more effective drugs and therapies. While the industry has begun attracting significant public funding and tax exemption, it still faces the challenges of short product lifecycles and of developing blockbuster drugs. The pharmaceuticals industry is dominated by the U.S., which holds around 45% of the global market share. However, the markets in emerging economies like in China and India are expected to show a double digit growth. This is because global pharmaceutical giants are increasingly outsourcing R&D to lower costs and to take advantage of the scientific work pool in these nations.
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Global Weight Loss and Diet Management Market (2009 - 2014)Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition. |
July 2009 | $ 4650 |
|
Autoimmune Treatment Market (2009 - 2014)The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market. |
September 2009 | $ 4650 |
|
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, ChinaThe prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come. |
April 2010 | $ 4650 |
|
Global Ophthalmology Drugs & Devices MarketGlobal ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders. |
May 2010 | $ 5650 |
|
US Neonatal (Preterm) Infant Care Market (2010-2015)Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market. |
June 2010 | $ 4650 |
|
Global Cancer Biomarkers Market (2010 - 2015)Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach an estimated 9.2 million deaths in 2015. The rising prevalence of the disease forms one of the major factors driving the growth of the oncology biomarkers market. |
June 2010 | $ 4650 |
|
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical devices and Health insurance)The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders. |
August 2010 | $ 4650 |
|
Effective Social Media Marketing Strategies for Pharmaceutical MarketIncreasing number of web users’ world wide (1.8 billion), development and popularity of web based community sites (Twitter, Facebook), tools and information centers (branded & unbranded sponsored communities) are changing approach towards Pharma and healthcare marketing and information sharing. In pharma industry social media has emerged as an effective tool for marketing, consumer engagement, monitoring & analyzing user generated content and building & changing brand perception. Social media is emerging as a strategic shift in organizations communication and operation model. Top pharmaceutical market players have started integrating social media in to their marketing mix. The effective social media marketing strategies that can help generate business exposure, market research data, relationship building and thus can prove as an important initiative to boom sales and overall business in the long term |
August 2010 | $ 4650 |
|
World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015)Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles. |
October 2010 | $ 4650 |
|
Global Pediatric Healthcare Market (2010 - 2015)Children often suffer from short term diseases related to respiratory or ocular infections. Apart from these, gastrointestinal infections accompanied by diarrhea and injury related disorders are common in children. Many times these are just short term diseases and treated on daily basis by pediatricians but treatment of these diseases consume large amount of time and financial resources of their parents and caregivers involved in primary care. Change in lifestyle has been a major factor for increased prevalence of such diseases. |
October 2010 | $ 4650 | |
Health Care Information Technology (HCIT) Market in BRIC (Brazil, Russia, India, China) 2010-2015Countries such as Brazil, India, China and Russia are moving ahead to adopt such modern technologies to minimize healthcare cost and to provide primary and secondary healthcare services to large rural population. Technology driven healthcare programs such as Telemedicine projects are growing in all four countries. Such projects are increasing use of healthcare information technology. Since these countries are still in emerging stage in terms of HCIT usage hence it is essential to start with basic healthcare IT solutions such as EMR’s and CPOE. These technologies in their basic form can be easily implemented at minimal cost, at least in urban healthcare institutions. Government initiatives towards healthcare system development and modernization are the major reasons behind HCIT growth in these countries. |
October 2010 | $ 4650 |
|
Clinical Trials Market in (Brazil, Russia, India, India) BRIC (2010 - 2015)Clinical trials market is evidencing a significant growth in emerging economies. India, especially is illustrating significant growth rate due to its large patient base with diverse gene pool that allows the Pharma companies and CROs to conduct clinical trials in more effective method. |
October 2010 | $ 4650 | |
Global Oncology Pharmaceuticals & Therapeutics MarketEach section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles. |
October 2010 | $ 4650 |
|
Global Colorectal Cancer Market (2010-2015)2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. |
October 2010 | $ 4650 |
|
Global Weight Loss and Diet Management Market (2010 - 2015)Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition. |
October 2010 | $ 4650 | |
Opportunity Analysis of H1N1 (swine flu) Vaccination MarketThe increase in public awareness and government initiatives, as a consequence of scare from pandemic flu has resulted in the drastic rise in demand for the Influenza Vaccines. This transient boost in demand of seasonal influenza vaccines is an impact of prevailing H1N1 pandemic, due to apprehension and lack of clarity among the general public. The emerging technologies in production are going to give a new face to the market dynamics of this market. The upcoming vaccines and drugs by various players in the market such as Novartis’ Optaflu and ProteinSciences’ FluBlock, along with the emerging technologies in production are going to give a new face to the market dynamics of this market. |
October 2010 | $ 4650 |
|
Global Active Pharmaceutical Ingredients (API) Market (2010 - 2015)As defined by USFDA active Pharmaceutical Ingredients (API’s) are ‘'any substance or mixture of substances intended to be used in the manufacture of a medicinal product and that, when used in the production of a drug becomes an active ingredient of the drug product'. |
October 2010 | $ 4650 | |
Monoclonal Antibodies Market (2010 - 2015)The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008. Monoclonal antibodies present significant opportunities as they are targeted therapy (They impact only the diseased cells and do not harm healthy cells) unlike chemotherapy drugs. |
October 2010 | $ 4650 | |
Global Chronic Lymphocytic Leukemia Market2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates. |
October 2010 | $ 4650 |
|
Diabetes Market (Devices and Drugs)Sedentary lifestyle has led to the increase in diabetic patients and increasing awareness of side effects caused if left undiagnosed has increased the number of patients turning out for diagnosis and regular check. Additionally diabetes devices has also been a leading market in home healthcare segment as well, with introduction of handy glucose monitors. The market is evidencing continued innovation addressing issues pertaining to painless and user friendly diagnostic devices, drugs with less side effects, Insulin delivery systems etc. The market dynamics in this industry compels the competitors to be aware of the competitive moves to enhance market revenues and retain market share |
October 2010 | $ 4650 | |
Top 25 OTC Drugs Market (2010 - 2015)Over the counter drugs can be broadly segmented as analgesics, topical medicines, cough and cold preparations, indigestion preparations, medicated skin products, first aid kits, plaster and bandages, traditional medicines and vitamins and minerals. Among all the OTC drugs cough and cold preparations lead the OTC healthcare market with almost 18% of market share. Johnson& Johnson, GlaxoSmithKline Plc and Novartis AG are the leading players of global OTC market. |
October 2010 | $ 4650 | |
HIV/AIDS - Therapies and Global Market (2009 - 2014)HIV/AIDS diagnosis and therapy is one of the most complex healthcare problem faced by the medical sector. This report keeps track of the latest diagnostics technologies developed and provides a comprehensive coverage of HIV tests and treatments with a special emphasis on the most affected regions of Africa and Asia. It also outlines the market potential and size of HIV tests, treatments and diagnostics. |
October 2010 | $ 4650 | |
Global Multiple Myeloma Drugs Market2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates. |
October 2010 | $ 4650 |
|
Global Breast Cancer Drugs MarketThere are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market. |
October 2010 | $ 4650 |
|
Anti Nicotine Therapies (2010 - 2015)Smoking cessation products are gaining popularity in both OTC and prescription products market segments. Increasing burden on healthcare system due to deteriorating quality of life because of smoking and several side effects associated with the current smoking cessation marketed products, builds up the need of novel products with better efficacy in this market. |
October 2010 | $ 4650 | |
Global Electronic Medical Record (EMR) Market (2010-2015)EMR is a part of healthcare information technology that is used to make paperless computerized patient data to increase efficiency of hospital systems and to reduce chances of errors in medical records. Substantial growth rate (more than 16%) of global healthcare IT spending is expected to push EMR development all over the globe. |
October 2010 | $ 4650 |
|
Global Non Small Cell Lung Cancer/Oncology Drugs Market2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. |
October 2010 | $ 4650 |
|
Global Weight Loss Drugs, Supplements And Cosmetics MarketIndividuals with high BMI have a greater risk of developing diseases such as cancer and diabetes. This holds true for both men and women; and those with BMI above 35 are at the highest risk. However, increasing awareness about obesity is encouraging consumers to seek medical assistance and consultation for weight reduction. The market for weight-loss drugs, cosmetics, and supplements is witnessing a significant growth as these do not involve strict diet or exercise regimens. Top pharmaceutical companies have thus increased R&D investments for anti-obesity drugs with minimal or no side effects. |
October 2010 | $ 4650 |
|
Sales Force Effectiveness (2009 - 2014)Pharmaceutical companies are aiming to increase their return on investment (ROI) from their sales representatives. Improvement in rep performance reduces ineffective sales calls, optimizes cost per detail and increases revenue per call. Companies are thus exploring all available options under their sales force effectiveness strategy. |
October 2010 | $ 4650 |
|
Custom Research
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/custom-research.asp to specify your custom Research Requirement
Search reports
